Scientists test supercharged flu shot

NCT ID NCT06507553

Completed ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

Summary

This study tested a new version of the seasonal flu vaccine that includes an extra component (an H3 strain) to see if it is safe and how well it triggers an immune response. It involved about 400 healthy adults, split into younger (18-49) and older (60+) groups, who received different doses. The main goal was to monitor for any side effects and measure the body's antibody production after vaccination.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Investigational Site Number : 0360001

Melbourne, Victoria, 3124, Australia
Investigational Site Number : 0360002

Botany, New South Wales, 2019, Australia
Investigational Site Number : 0360003

Southport, Queensland, 4222, Australia
Investigational Site Number : 0360004

Sippy Downs, Queensland, 4556, Australia
Investigational Site Number : 0360005

Morayfield, 4506, Australia
Investigational Site Number : 0360007

Adelaide, South Australia, 5067, Australia
Investigational Site Number : 0360010

Brookvale, New South Wales, 2100, Australia
Investigational Site Number : 0360011

Miranda, New South Wales, 2228, Australia
Investigational Site Number : 0360012

Maroubra, New South Wales, 2035, Australia
Investigational Site Number : 0360013

Taringa, Queensland, 4068, Australia

Conditions

Explore the condition pages connected to this study.

HEALTHY VOLUNTEERS INFLUENZA